Dr. Rabinovici participates in patient evaluations and management. On the research front, he leads the MAC PET imaging program, is principal investigator of a cohort study of early-onset Alzheimer’s disease and of Imaging Dementia: Evidence for Amyloid Scanning (IDEAS), a U.S.-wide study sponsored by the Centers for Medicare and Medicaid Services to assess the clinical utility of amyloid PET in 18,500 Medicare beneficiaries. His work investigates how structural, functional and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and to study the biology of neurodegenerative diseases, with the goal of accelerating treatment development.